New Stock News | Di Li Intelligent Delivery Board of Hong Kong Stock Exchange

06:37 11/02/2026

According to the disclosure of the Hong Kong Stock Exchange on February 10th, Shenzhen Di Ling Intelligent Technology Co., Ltd. (referred to as "Di Ling Intelligent") has submitted an application for listing on the main board of the Hong Kong Stock Exchange, and Minyi Capital is its exclusive sponsor.

According to the disclosure of the Hong Kong Stock Exchange on February 10th, Shenzhen Diling Intelligent Technology Co., Ltd. (referred to as Diling Intelligent) submitted its listing application to the main board of the Hong Kong Stock Exchange, with CMBC CAPITAL as its exclusive sponsor. The prospectus revealed that Diling Intelligent is a leading provider of enterprise AI intelligent body solutions in China. The company is committed to developing AI intelligent body solutions to enhance efficiency, scalability, and precision for customers. According to Frost & Sullivan, in terms of revenue in 2024, the company has become the fifth largest supplier of enterprise AI intelligent body solutions in China, with a market share of 3.0%.

Consumer demand driven, HUITONGDA NET (09878) hard discount supermarket "accelerates upgrade"

WUXI BIO (02269) YINGXI: Shareholders' net profit in 2025 increased by 46.3% year-on-year.

ABBISKO-B(02256): The FGFR4 inhibitor erdafitinib has completed the global phase I study extension stage with the first patient dosed in the United States.

Consumer demand driven, HUITONGDA NET (09878) hard discount supermarket "accelerates upgrade"

WUXI BIO (02269) YINGXI: Shareholders' net profit in 2025 increased by 46.3% year-on-year.

ABBISKO-B(02256): The FGFR4 inhibitor erdafitinib has completed the global phase I study extension stage with the first patient dosed in the United States.